ACXP · Forms 3, 4, 5
Insider trades at Acurx Pharmaceuticals, Inc.
No open-market insider buys or sells at Acurx Pharmaceuticals, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Acurx Pharmaceuticals, Inc. (ACXP) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Acurx Pharmaceuticals, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Carl Sailer | Director | Options or other derivatives | Form 4 | ||||
| Jack H Dean | Director | Options or other derivatives | Form 4 | ||||
| James J. Donohue | Director | Options or other derivatives | Form 4 | ||||
| Thomas L Harrison | Director | Options or other derivatives | Form 4 | ||||
| Joseph C Scodari | Director | Options or other derivatives | Form 4 | ||||
| Robert J Deluccia | Director | Options or other derivatives | Form 4 | ||||
| David P Luci | President and CEO | Options or other derivatives | Form 4 | ||||
| Robert G. Shawah | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| Robert G. Shawah | Chief Financial Officer | Options or other derivatives | Form 4 | ||||
| David P Luci | President and CEO | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.